Urine tumour associated trypsin inhibitor (TATI) in diagnosis and prognosis of transitional cell carcinoma of the bladder
Authors:
- Michael PešlMPMichael Pešl
- Marko BabjukMBMarko Babjuk
Open Access
- 20 April 2015
- journal article
- Published by Care Comm in Czech Urology
- Vol. 19 (1) , 44-50
Abstract
Pe?l M. V?znam stanoven? mo?ov? hladiny TATI (tumour associated trypsin inhibitor) pro diagnostiku a progn?zu tumor? mo?ov?ho m?ch??e. C?lem pr?ce je zhodnotit v?znam stanoven? hladiny TATI (tumour associated trypsin inhibitor) v mo?i p...Keywords
This publication has 9 references indexed in Scilit:
- Association of tumor-associated trypsin inhibitor (TATI) expression with molecular markers, pathologic features and clinical outcomes of urothelial carcinoma of the urinary bladderWorld Journal of Urology, 2011
- Evaluation of Urine Tumor-Associated Trypsin Inhibitor, CYFRA 21-1, and Urinary Bladder Cancer Antigen for Detection of High-Grade Bladder CarcinomaUrology, 2008
- Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC TrialsEuropean Urology, 2006
- Tumor-associated trypsin inhibitor as a prognostic factor during follow-up of bladder cancerUrology, 2003
- Identification of Genes Up-Regulated in Urothelial TumorsThe American Journal of Pathology, 2003
- TPA, TATI, CEA, AFP, β-HCG, PSA, SCC, and CA 19-9 for Monitoring Transitional Cell Carcinoma of the BladderAmerican Journal of Clinical Oncology, 1996
- Tumour-Associated Trypsin Inhibitor and Renal Cell CarcinomaEuropean Urology, 1995
- Tumour-associated trypsin inhibitor (TATI): comparison with CA125 as a preoperative prognostic indicator in advanced ovarian cancerBritish Journal of Cancer, 1994
- Evaluation of Tati and Other Markers in Solid TumorsScandinavian Journal of Clinical and Laboratory Investigation, 1991